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Abstract
Background: Chronic non-specific low back pain (LBP) is a prevalent (80%) and multi-dimensional illness. This study 
aims to test whether acupuncture, baclofen, or combined treatment with acupuncture and baclofen alleviates 
symptoms of non-specific chronic LBP in men.
Methods: Eight-four (84) men aged 50-60 years with non-specific chronic LBP were randomly assigned to four groups: 
the baclofen group received only baclofen (30 mg/day); the acupuncture group received only acupuncture at selected 
acupoints; the acupuncture + baclofen group received combined treatment with acupuncture and baclofen 
treatments; and the control group received no pain reduction treatment. After five weeks of treatment, visual analogue 
scale (VAS) and self-reported pain disability with the Roland-Morris Disability Questionnaire (RDQ) were conducted for 
outcome measures.
Results: After treatment, the baclofen, acupuncture and acupuncture + baclofen groups all had lower VAS and RDQ 
scores. Significantly higher reduction and improvement in VAS and RDQ scores were found in the acupuncture and 
acupuncture + baclofen groups compared to the baclofen group.
Conclusion: The present study indicates that the combined treatment of acupuncture and baclofen is more effective 
than baclofen treatment alone to reduce pain in patients with non-specific chronic LBP.
Trial registration number: ACTRN12609000698279
Background
Low back pain (LBP) may be the most prevalent illness,
with 80% of the population experiencing it at least once in
their lifetime [1]. Up to 90% of all patients with acute LBP
recover quickly with or without treatment [2,3]. Ten to
forty percent of all LBP cases become chronic which is a
burden on the society [4,5]. Furthermore, LBP is a multi-
dimensional problem [6] involving pathoanatomical, neu-
rophysiological, physical and psychosocial factors [7].
Most LBP cases are non-specific as definitive diagnosis
cannot be established with current radiological methods
[4]. The results of research on the effectiveness of treat-
ments for non-specific chronic LBP are inconsistent [8,9].
Some studies suggest that the classification of chronic
LBP disorders should be homogenous so that specific
interventions tailored for these homogenous groups can
be more effective [9]. The most common medications for
non-specific LBP are skeletal muscle relaxants and opioid
analgesics [8,10]. Muscle relaxants are used to reduce
pain of patients with non-specific LBP and, in particular,
non-benzodiazepine muscle relaxants such as baclofen
are used for symptomatic treatment of chronic LBP
[8,11]. Some researchers found that muscle relaxants
including baclofen are ineffective [9]. Thus, the use of
muscle relaxants for LBP remains controversial. When
these drugs are not adequate, another kind of therapy, e.g.
acupuncture, is often sought [12,13]. Acupuncture stimu-
lates specific points on the body surface with fine needles
[14] and relieves pain in chronic LBP patients as accepted
by the World Health Organization (WHO) [15]. Acu-
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puncture treatment may improve the disability of patients
with LBP [13,16]. While acupuncture is widely used by
patients with chronic LBP, its effectiveness in pain reduc-
tion still lacks evidence [12,17,18]. A couple of ran-
domised controlled trials found that combined treatment
with acupuncture and baclofen were effective in pain
reduction [11,18]; however, the efficacy of this combina-
tion has not been demonstrated for non-specific chronic
LBP. This study aims to test whether acupuncture,
baclofen and combined treatment with acupuncture and
baclofen can alleviate symptoms of non-specific chronic
LBP in men.
Methods
Participants
Men aged 50-60 years with non-specific chronic LBP
were recruited through local newspapers except for a few
patients (eight people) who had contacted the trial
research centres of the Tehran University of Medical Sci-
ences (TUMS). Screening of participants was carried out
by a qualified musculoskeletal physiotherapist. Partici-
pants met all the following inclusion criteria: (1) lumbar
or lumbosacral pain for six months or longer; (2) no radi-
ation of low back pain to other regions; (3) normal neuro-
logical signs of lumbosacral nerves including deep tendon
and plantar reflexes, voluntary motor function, straight
leg raise and sensory function; (4) no acupuncture treat-
ment in the past six months; (5) absence of significant
p a t h o l o g y  s u c h  a s  b o n e  f r a c t u r e  o r  s e v e r e  p s y c h i a t r i c
conditions; (6) stable health; and (7) all participants expe-
rienced ongoing pain, the intensity of which did not
change over the course of a day. Patients were excluded if
they had any of the following: (1) major trauma or sys-
temic disorders; (2) conflicting or ongoing co-interven-
tions (drugs and/or alternative treatments); (3) prior use
of acupuncture for LBP in the past six months; (4) refusal
to be randomised; (5) protrusion or prolapse of one or
more intervertebral discs with concurrent neurological
symptoms; (6) prior vertebral column surgery; (7) infec-
tious spondylopathy; (8) low back pain secondary to an
inflammatory, malignant or autoimmune disease; (9)
congenital deformation of the spine (except for slight lor-
dosis or scoliosis); or (10) compression fracture caused by
osteoporosis, spinal stenosis, spondylolysis or spon-
dylolisthesis [13,19]. At the first appointment, patient
characteristics and baseline measurements were
recorded. Part of the screening process relied on self-
reported information concerning current medical condi-
tions, medications and serious injuries. Before signing a
written informed consent, each participant was given an
information sheet explaining the nature of the study. This
study was approved by the Ethics Committee of the
TUMS.
Treatments
Based on the information of our planned sample size in
previous studies [18] and according to the need for ade-
quate statistical power, a sample size of 84 participants
(21 per group) was considered both appropriate and fea-
s i b l e .  P a r t i c i p a n t s  w e r e  r a n d o m l y  a s s i g n e d  t o  f o u r
groups: control (C), acupuncture (AC), baclofen (BA) and
baclofen plus acupuncture (BA+AC). Participants were
randomised with a stratified blocked randomisation
scheme (with random block size of four) and statistical
software for randomization (Sample Size version 2.0,
Intelligent Masters Company, USA). Block randomiza-
tion design of 4 (i.e. for every 4 subjects recruited, 1 was
assigned in AC group, 1 was assigned in the BA, 1 was
assigned in BA+AC group, and 1 was assigned in the C
group), was used to ensure balance of the numbers in
each group. Stratification was also done based on the ini-
tial characteristics shown in Table 1 (VAS and RDQ
scores). Participants' assignments were concealed in
sealed opaque envelopes that were opened by the acu-
puncturist before treatment. No assignment was reused
with another patient once the envelope had been opened.
Treatment course for all groups was five weeks, i.e.
standard for chronic pain treatment [19,20]. Control
group did not receive any treatment for chronic pain. All
participants were advised to maintain their normal life-
style and not to start any new medications. Acupuncture
reporting followed the STandards for Reporting Interven-
tions in Clinical Trial of Acupuncture (STRICTA) [14].
Participants in the AC and BA+AC groups received acu-
puncture treatment performed by a certified acupunctur-
ist twice a week for five weeks. Acupuncture protocol
used in this study was consistent with the neurohumoral
mechanism theory of acupuncture [21]. Each patient
received needles bilaterally in the following acupoints:
Shenshu  (BL23),  Dachangshu  (BL25),  Panguanshu
(BL28), Ciliao (BL32), Kunlun (BL60), Huantiao (GB30)
and  Yanglingquan  (GB34). An aseptic procedure was
employed with disposable, stainless 30-gauge needles
coupled with electrical stimulation at 4-6 Hz with pulse
duration of 0.5 ms [22]. Needles (0.2 mm × 40 mm, Seirin,
USA) were inserted into the acupoints until the patient
felt dull pain or deqi. At each session 10-12 needles were
used bilaterally and needles were left in place for 20-25
minutes. Baclofen was orally administered 30 mg/day (15
mg  bid) which is the recommended effective dose for
chronic LBP [23] without causing motor impairment
[23]. Patients in the BA+AC group received both baclofen
(30 mg/day) and acupuncture for five weeks.
Outcome measures
Primary outcomes were pain intensity quantified with a
10 cm visual analogue scale (VAS, 0-100 mm) [24] and
self-reported pain disability assessed with an Iranian ver-Zaringhalam et al. Chinese Medicine 2010, 5:15
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sion of the Roland Morris Questionnaire (RDQ, 0-24
points) which is a reliable and valid instrument for mea-
suring functional status in Persian-speaking patients with
LBP [25,26]. VAS scores were measured immediately
before the first treatment and subsequently at one, two,
three, four, five and ten weeks after the first treatment.
RDQ scores were measured immediately before the first
treatment and subsequently at five and ten weeks after
the first treatment. Each VAS or RDQ score was mea-
sured immediately before treatment at the specified week
[19,27]. The concept of the minimal clinically important
difference (MCID) [28], helped interpret changes in VAS
and RDQ scores at the individual level. If available, MCID
in these outcome measures were defined as a 2-point
reduction on VAS and 2.5 points reduction on RDQ.
Statistical analysis
Data are presented as mean (SD). Statistica software (ver-
sion 6.0, StatSoft, USA) was used in all statistical analy-
ses. One-way analysis of variance (ANOVA) was
performed followed by post-hoc Tukey's multiple com-
parison test (Statistica version 6.0) to determine signifi-
cant differences in VAS and RDQ scores between groups.
Independent t-test was used for comparison of VAS or
RDQ scores between two different groups. Statistical sig-
nificance level was set at P < 0.05.
Results
Participants
Participants were recruited between May 2006 and Feb-
ruary 2008. Of the 125 respondents, 84 (67.2%) met the
inclusion criteria for participants. Four participants
dropped out from the trial during the treatment due to
lack of time (n = 2) and pain from acupuncture (n = 2).
Follow-up measurements and analyses were performed
on the remaining 80 participants who completed the
study (Figure 1). There was no significant difference in
b a s e l i n e  v a r i a b l e s  s u c h  a s  a g e ,  d i s e a s e ,  V AS  a n d  R DQ
scores between groups (Table 1).
Changes in VAS scores for pain intensity
VAS scores for pain intensity decreased significantly in all
treatment groups; however, the exact time course varied
(Table 2). The BA group showed a significant decrease in
VAS at one and two weeks of treatment compared to
baseline (P < 0.001) and the control group (P = 0.008).
Baclofen was more effective in pain reduction in the first
week of treatment than in the second week (P = 0.04).
VAS analysis in the BA group found no significant differ-
ence between baselines, three, four, five and ten weeks of
treatment. Acupuncture significantly decreased the pain
intensity after five weeks of treatment and this effect was
stable up to the tenth week of the study. VAS demon-
strated a significant decrease at the first week after treat-
ment compared to baseline and control group (P = 0.009).
VAS in the AC group decreased significantly at two,
t h r e e ,  f o u r  a n d  f i v e  w e e k s  c o m p a r e d  t o  b a s e l i n e  ( P  <
0.001) and one week of treatment (P = 0.02). Moreover,
acupuncture reduced pain intensity more than baclofen
at two, three, four and ten weeks of treatment. The
BA+AC group showed a significant reduction in VAS at
all time points of this study (P < 0.001). VAS scores were
significantly lower in the BA+AC group than those in the
AC group (P = 0.04) (Figure 2).
Changes in RDQ scores for pain disability
While the interventions decreased RDQ scores in all
groups, the exact time course varied (Table 3). Baclofen
administration significantly decreased the RDQ scores
after five weeks of treatment compared to zero (P = 0.04)
Table 1: Baseline participant characteristics
Group Number of 
participant
Age Education Pain 
duration 
(years)
BMI Base RDQ 
score
Base VAS 
score
High 
school or 
less
Technical 
school
College 
graduate
C 20 54.3 (4.2) 12 2 6 7 31 (3.5) 9.7 (4.4) 64.5 (19.3)
BA 20 55.1 (3.3) 13 2 5 6.7 29.2 (4.2) 9.8 (4.2) 64.5 (18.3)
AC 20 54.2 (5.4) 12 3 5 7.1 32.5 (3.3) 9.6 (3.9) 64.3 (17.8)
BA+AC 20 54.2 (5.6) 13 1 6 6.9 30.3 (4.1) 9.5 (2.8) 64.6 (16.8)
P-value >0.7 >0.05 >0.4 >0.3 >0.5 >0.5
Data are presented as mean (SD).
BMI: body mass indexZaringhalam et al. Chinese Medicine 2010, 5:15
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and ten weeks (P = 0.04). RDQ scores in the AC and
BA+AC groups significantly decreased at both five and
ten weeks compared to baseline (P < 0.001). There were
significant decreases in RDQ scores in the AC and
BA+AC groups compared to the BA group at five (P <
0.001) and ten weeks (P  < 0.001). RDQ scores in the
BA+AC group were also significantly lower than those in
the AC group throughout the study (P = 0.04) (Figure 3).
Discussion
The AC and BA+AC treatments for non-specific chronic
LBP were more effective in pain reduction than baclofen
Figure 1 Participants flow in the study.
Table 2: Pain intensity scores (VAS) in experimental groups
Group
(n = 20)
Weeks
0123451 0
C 64.5 (19.3) 64.2 (21.1) 64.1 (19.4) 64.1 (22.3) 64.3 (20.1) 64.3 (23.8) 64.2 (25.5)
BA 64.5 (18.3) 52.8 (19.4)# 55.1 (21.1) 62.1 (18.7) 63 (20.2) 61.9 (22.3) 63.7 (24.4)
AC 64.3 (17.8) 56.5 (19.9) 50.5 (20.1)# 49.1 
(19.3)###
47.3 
(18.9)###
47 (19.1)### 50.1 
(20.3)###
BA+AC 64.6 (16.8) 52.1 (15.9)‡ 45.1 (15.2)‡ 45.6 (14.7)‡ 42.3 (13.9)‡ 40.1 (13.3)‡ 47.3 (14.1)‡
Data are presented as mean (SD).
‡ P < 0.05: comparing BA+AC with AC
# P < 0.05, ### P < 0.001: comparing AC with BAZaringhalam et al. Chinese Medicine 2010, 5:15
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treatment alone. Moreover, the anti-nociceptive effects in
the AC and BA+AC groups were also more persistent at
follow-ups. Acupuncture has demonstrated its potential
as a promising treatment for chronic LBP [29,30]. While a
number of theories of how acupuncture may treat LBP
are available, no accepted mechanism has emerged
[30,31]. Similar to descending inhibitory and/or diffuse
noxious inhibitory controls in the central nervous system,
acupuncture may stimulate the small-diameter afferent
fibres, which then reduce the transmission of pain signals
thereby inhibiting pain discrimination and perception
[32]. Low back muscle spasm and muscle blood flow
decrease are the main underlying causes of chronic LBP
[33]. Acupuncture alleviates tension and improves blood
flow in the treated muscles [34]. Thus, acupuncture treat-
ment may improve lumbar function and reduce pain via
i n c r e a s i n g  t h e  b l o o d  f l o w  t o  t h e  a f f e c t e d  r e g i o n  [ 3 5 ] .
Non-benzodiazepine muscle relaxants are often used to
treat non-specific LBP [36], as a gamma-aminobutyric
a c i d  ( G A B A )  d e r i v a t i v e  w i t h  c e n t r a l  n e r v o u s  s y s t e m
action and a substance P antagonist [37,38]. In this study
baclofen (30 mg/day per oral) reduced the pain intensity
but only effective in the first two weeks. These results are
Figure 3 RDQ scores for pain disability. (A) Comparison between 
control and AC, BA or BA+AC. (B) Comparison between AC, BA and 
BA+AC. * P < 0.05. *** P < 0.001.
 
Figure 2 VAS scores for pain intensity. (A) Comparison between 
control and AC, BA or BA+AC. (B) Comparison between AC, BA and 
BA+AC. * P < 0.05. ** P < 0.01. *** P < 0.001.
 
Table 3: Ronald Morris Questionnaire (RDQ) scores in experimental groups
Group
(n = 20)
Week
05 1 0
C 9.7 (4.4) 9.8 (3.9) 9.9 (4.6)
BA 9.8 (4.2) 8.8 (3.8) 9.5 (4.1)
AC 9.6 (3.9) 6.4 (2.9)‡ 7.2 (3.1)‡
BA+AC 9.5 (2.8) 5.7 (1.4)### 5.8###
Data are presented as mean (SD).
‡ P < 0.05: comparing AC with BA+AC
### P < 0.001: comparing BA+AC with BAZaringhalam et al. Chinese Medicine 2010, 5:15
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in line with a previous study that did not find significant
and consistent decrease in pain intensity with baclofen
treatment for chronic spastic pain [39]. Due to the con-
troversies some practitioners are reluctant to prescribe
baclofen to their patients [9]. Baclofen is effective for
immediate pain relief [24], whereas acupuncture is effec-
tive to treat long-term pain and alleviate pain-related dis-
abilities [27,40,41]. As baclofen treatment alone does not
produce major functional benefits [42], combination
treatment maybe an alternative [43]. This RCT does show
that the BA+AC group had lower VAS and RDQ scores
than other groups, i.e., the combined acupuncture and
baclofen treatment is more effective to treat non- specific
chronic LBP than either treatment alone [44].
Conclusion
The present study indicates that the combined treatment
of acupuncture and baclofen is more effective than
baclofen treatment alone to reduce pain in patients with
non-specific chronic LBP.
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